Liberia vs Peru: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Liberia
80.0%
in 2025
Peru
80.0%
in 2025
Liberia rank
116th
Peru rank
116th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Liberia
- Peru
How they compare
Liberia currently reports 80.0% against 80.0% in Peru, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Peru ahead.
Liberia ranks 116th and Peru ranks 116th of 192 countries.
Peru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Liberia | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 4.5% | 4.5% | Peru |
| 2010s | 35.8% | 83.7% | 47.9% | Peru |
| 2020s | 74.0% | 76.7% | 2.7% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Liberia or Peru?
- Liberia, at 80.0% against 80.0% in Peru as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Liberia and Peru?
- 0.0%, with Liberia ahead.
- How many years of comparable data are there for Liberia and Peru?
- 18 years are reported by both, from 2008 to 2025.
- How do Liberia and Peru rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Liberia ranks 116th and Peru ranks 116th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.